Coming to the latest development around Olivia, the investors are optimistic, evident from the stock surge last week.

Analyst discusses AI stock Tempus AI, highlighting potential for profitability by 2025, insider selling, and sector risks.

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

In a regulatory filing on Friday, Tempus AI (TEM) disclosed that Chairman and CEO Eric Lefkofsky sold a series of shares ...

TEM's Genomics unit is expected to report strong growth for the fourth quarter, banking on continued unit growth pick-up.

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look ...

Shares of Tempus AI climbed more than 5% on Thursday afternoon, poised for their longest winning streak since August 2024.

Tempus AI stock had its best day on record on Tuesday after the medical tech company launched an AI-powered health concierge ...

Shares of Tempus AI (NASDAQ:TEM) are soaring 36% higher in midday trading after it was revealed former House Speaker Nancy ...

Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free ...

In addition to gains powered by Pelosi's options purchase disclosure, Tempus Ai stock is also getting a boost from the rollout of its AI-powered olivia healthcare app. The software is designed to ...

Tempus AI Inc (NASDAQ:TEM) shares are trading higher Tuesday after former House Speaker Nancy Pelosi disclosed a new position ...